Syndax to Announce First Quarter 2025 Financial Results and Host Conference Call and Webcast on May 5, 2025

Conference ID: Syndax1Q25 Domestic Dial-in Number: 800-590-8290 International Dial-in Number: 240-690-8800 Live webcast: https://sndx-1q25.open-exchange.net/registration NEW YORK, April 28, 2025 (GLOBE NEWSWIRE) -- Syndax Pharmaceuticals (Nasdaq: SNDX), a commercial-stage biopharmaceutical company developing an innovative pipeline of cancer therapies, today announced that it will report its first quarter 2025 financial results and provide a business update on Monday, May 5, 2025. In connection with the earn ...